|
1
|
Gridelli C, Rossi A, Carbone DP, Guarize
J, Karachaliou N, Mok T, Petrella F, Spaggiari L and Rosell R:
Non-small-cell lung cancer. Nat Rev Dis Primers. 1:150092015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ettinger DS, Akerley W, Bepler G, Blum MG,
Chang A, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Ganti AK, et
al: Non-small cell lung cancer. J Natl Compr Canc Netw. 8:740–801.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chang JY, Senan S, Paul MA, Mehran RJ,
Louie AV, Balter P, Groen HJ, McRae SE, Widder J, Feng L, et al:
Stereotactic ablative radiotherapy versus lobectomy for operable
stage I non-small-cell lung cancer: A pooled analysis of two
randomised trials. Lancet Oncol. 16:630–637. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Vansteenkiste J, Crinò L, Dooms C,
Douillard JY, Faivre-Finn C, Lim E, Rocco G, Senan S, Van Schil P,
Veronesi G, et al: 2nd ESMO Consensus Conference on Lung Cancer:
Early-stage non-small-cell lung cancer consensus on diagnosis,
treatment and follow-up. Ann Oncol. 25:1462–1474. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lalevée S and Feil R: Long noncoding RNAs
in human disease: Emerging mechanisms and therapeutic strategies.
Epigenomics. 877–879. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bhan A and Mandal SS: Long noncoding RNAs:
Emerging stars in gene regulation, epigenetics and human disease.
ChemMedChem. 9:1932–1956. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang YR, Zang SZ, Zhong CL, Li YX, Zhao SS
and Feng XJ: Increased expression of the lncRNA PVT1 promotes
tumorigenesis in non-small cell lung cancer. Int J Clin Exp Pathol.
7:6929–6935. 2014.PubMed/NCBI
|
|
9
|
Lu KH, Li W, Liu XH, Sun M, Zhang ML, Wu
WQ, Xie WP and Hou YY: Long non-coding RNA MEG3 inhibits NSCLC
cells proliferation and induces apoptosis by affecting p53
expression. BMC Cancer. 13:4612013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liang WC, Ren JL, Wong CW, Chan SO, Waye
MM, Fu WM and Zhang JF: LncRNA-NEF antagonized epithelial to
mesenchymal transition and cancer metastasis via cis-regulating
FOXA2 and inactivating Wnt/β-catenin signaling. Oncogene.
37:1445–1456. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shaw RJ: Glucose metabolism and cancer.
Curr Opin Cell Biol. 18:598–608. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rudlowski C, Becker AJ, Schroder W, Rath
W, Büttner R and Moser M: GLUT1 messenger RNA and protein induction
relates to the malignant transformation of cervical cancer. Am J
Clin Pathol. 120:691–698. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang J, Lin J, Liu T, Chen T, Pan S, Huang
W and Li S: Analysis of lncRNA expression profiles in non-small
cell lung cancers (NSCLC) and their clinical subtypes. Lung Cancer.
85:110–115. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hori SS and Gambhir SS: Mathematical model
identifies blood biomarker-based early cancer detection strategies
and limitations. Sci Transl Med. 3:109ra1162011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xie J, Wu H, Dai C, Pan Q, Ding Z, Hu D,
Ji B, Luo Y and Hu X: Beyond Warburg effect-dual metabolic nature
of cancer cells. Sci Rep. 4:49272014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zheng J: Energy metabolism of cancer:
Glycolysis versus oxidative phosphorylation (Review). Oncol Lett.
4:1151–1157. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dang CV, Le A and Gao P: MYC-induced
cancer cell energy metabolism and therapeutic opportunities. Clin
Cancer Res. 15:6479–6483. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Alakus H, Batur M, Schmidt M, Drebber U,
Baldus SE, Vallböhmer D, Prenzel KL, Metzger R, Bollschweiler E,
Hölscher AH and Mönig SP: Variable 18F-fluorodeoxyglucose uptake in
gastric cancer is associated with different levels of GLUT-1
expression. Nucl Med Commun. 31:532–538. 2010.PubMed/NCBI
|
|
20
|
Levine AJ and Puzio-Kuter AM: The control
of the metabolic switch in cancers by oncogenes and tumor
suppressor genes. Science. 330:1340–1344. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Semaan A, Munkarah AR, Arabi H,
Bandyopadhyay S, Seward S, Kumar S, Qazi A, Hussein Y, Morris RT
and Ali-Fehmi R: Expression of GLUT-1 in epithelial ovarian
carcinoma: Correlation with tumor cell proliferation, angiogenesis,
survival and ability to predict optimal cytoreduction. Gynecol
Oncol. 121:181–186. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hevia D, Gonzalez-Menendez P, Cepas V and
Sainz RM: P 234-Glut 1 overexpression prevents glucose
deprivation-induced prostate cancer cell death by increasing
pentose phosphate pathway and glutathione. Free Radic Biol Med. 108
Suppl 1:S992017. View Article : Google Scholar
|
